| 000 | 01853 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250511214437.0 | ||
| 264 | 0 | _c19900726 | |
| 008 | 199007s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/0140-6736(90)91373-i _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKhamashta, M A | |
| 245 | 0 | 0 |
_aAssociation of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cJun 1990 |
||
| 300 |
_a1541-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAutoantibodies _xanalysis |
| 650 | 0 | 4 |
_aBlood Coagulation Factors _ximmunology |
| 650 | 0 | 4 |
_aCardiolipins _ximmunology |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aEchocardiography, Doppler _xmethods |
| 650 | 0 | 4 | _aEvaluation Studies as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHeart Valve Diseases _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xanalysis |
| 650 | 0 | 4 |
_aImmunoglobulin M _xanalysis |
| 650 | 0 | 4 | _aLupus Coagulation Inhibitor |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMitral Valve Insufficiency _xcomplications |
| 650 | 0 | 4 |
_aPhospholipids _ximmunology |
| 650 | 0 | 4 | _aProspective Studies |
| 700 | 1 | _aCervera, R | |
| 700 | 1 | _aAsherson, R A | |
| 700 | 1 | _aFont, J | |
| 700 | 1 | _aGil, A | |
| 700 | 1 | _aColtart, D J | |
| 700 | 1 | _aVázquez, J J | |
| 700 | 1 | _aParé, C | |
| 700 | 1 | _aIngelmo, M | |
| 700 | 1 | _aOliver, J | |
| 773 | 0 |
_tLancet (London, England) _gvol. 335 _gno. 8705 _gp. 1541-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0140-6736(90)91373-i _zAvailable from publisher's website |
| 999 |
_c1978670 _d1978670 |
||